German drugmaker Bayer (BAYGn.DE) was looking to place about 1.5 billion euros ($1.6 billion) worth of shares in its chemicals subsidiary Covestro (1COV.DE) late on Tuesday, a person familiar with the open market...
Perrigo sells Tysabri royalty stream, delays annual report
Drugmaker Perrigo Co Plc (PRGO.N) said on Monday it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo said it would delay the...
Daiichi moves to block Fortis stake sale again
Japanese pharmaceutical firm Daiichi Sankyo has again asked the Delhi High Court to block any stake sales by former RanbaxyBSE 5.63 % promoters Malvinder and Shivinder Singh as it battles to recover more than Rs 2,500...
Icahn buys Bristol-Myers shares, adding to activist pressure
Billionaire investor Carl Icahn has taken a stake in Bristol-Myers Squibb Co (BMY.N) and sees the drugmaker as a possible takeover target, according to a report published on Tuesday that sent the company’s shares...
Germany’s Stada has received a third, higher takeover offer
German generic drugs company Stada (STAGn.DE) said on Thursday it had received its third takeover approach, and at 58 euros ($61.89) per share, the latest offer was two euros higher than rival suitor Cinven...
How Sanofi lost out to J&J in $30 billion battle for Actelion
Swiss biotech company Actelion (ATLN.S), days before agreeing to a $30 billion bid by Johnson & Johnson (JNJ.N), found a rival offer to be as attractive but went with J&J because its offer provided more...
Integra to buy J&J’s Codman neurosurgery business for $1.05 billion
Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson’s Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the United States. Integra...
Stada receives takeover bids from Cinven & Advent International
Stada Arzneimittel AG, the German manufacturer of generic and OTC (over-the-counter) drugs, has confirmed that it has received two legally non-binding expressions of interest regarding a bid for the acquisition of up to...
Drugmaker Stada confirms takeover bid from two companies
German generic drugmaker Stada (STAGn.DE) said it has received two offers for the acquisition of the company, one of which is private equity group Cinven Partners LLP. Cinven is offering a price of 56 euros per Stada...
Sanofi nears deal to sell some over-the-counter drugs to Ipsen: Bloomberg
Drugmaker Sanofi (SASY.PA) is close to selling some over-the-counter products to Ipsen SA (IPN.PA), in a deal that could be valued at nearly 100 million euros ($106.18 million), Bloomberg reported. The deal between the...
Acquisitions will be critical for building Lupin’s specialty drugs business: Nilesh Gupta
Maker of generic (or off patent) drugs Lupin Ltd, plans to build a portfolio of specialty products for the US market through acquisitions in areas of women’s health, pediatrics and neurology, managing director Nilesh...
Aurobindo Pharma buys 4 biosimilar products from TL Biopharmaceutical
Aurobindo Pharma Ltd Thursday said it has acquired four biosimilar products from Swiss firm TL Biopharmaceutical AG of for an undisclosed amount. As part of this agreement, TL Biopharmaceutical will supply all the...
